La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Neurotech International Résultats passés
Passé contrôle des critères 0/6
Neurotech International's earnings have been declining at an average annual rate of -10.5%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 64.4% per year.
Informations clés
-10.5%
Taux de croissance des bénéfices
39.7%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 5.8% |
Taux de croissance des recettes | 64.4% |
Rendement des fonds propres | -103.9% |
Marge nette | -155.5% |
Dernière mise à jour des bénéfices | 31 Dec 2023 |
Mises à jour récentes des performances passées
Recent updates
Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
Jan 28We Think Neurotech International (ASX:NTI) Needs To Drive Business Growth Carefully
Oct 14Here's Why We're Not Too Worried About Neurotech International's (ASX:NTI) Cash Burn Situation
Jul 01Is Neurotech International (ASX:NTI) In A Good Position To Invest In Growth?
Jan 21Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?
Oct 06Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
May 18We're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn Rate
Dec 21Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 04Need To Know: Neurotech International Limited (ASX:NTI) Insiders Have Been Selling Shares
Dec 08Ventilation des recettes et des dépenses
Comment Neurotech International gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 Dec 23 | 3 | -5 | 2 | 6 |
30 Sep 23 | 2 | -6 | 2 | 6 |
30 Jun 23 | 1 | -8 | 3 | 6 |
31 Mar 23 | 1 | -6 | 3 | 5 |
31 Dec 22 | 2 | -5 | 3 | 3 |
30 Sep 22 | 1 | -4 | 2 | 3 |
30 Jun 22 | 1 | -3 | 1 | 3 |
31 Mar 22 | 0 | -4 | 2 | 4 |
31 Dec 21 | 0 | -6 | 2 | 5 |
30 Sep 21 | 0 | -7 | 2 | 5 |
30 Jun 21 | 0 | -7 | 2 | 5 |
31 Mar 21 | 0 | -6 | 2 | 3 |
31 Dec 20 | 0 | -5 | 2 | 0 |
30 Sep 20 | 0 | -3 | 1 | 0 |
30 Jun 20 | 0 | -2 | 1 | 0 |
31 Mar 20 | 0 | -3 | 1 | 0 |
31 Dec 19 | 0 | -4 | 2 | 0 |
30 Sep 19 | 0 | -4 | 2 | 0 |
30 Jun 19 | 0 | -5 | 2 | 0 |
31 Mar 19 | 0 | -4 | 2 | 0 |
31 Dec 18 | 0 | -4 | 3 | 0 |
30 Sep 18 | 0 | -4 | 3 | 0 |
30 Jun 18 | 0 | -4 | 3 | 0 |
31 Mar 18 | 0 | -4 | 3 | 0 |
31 Dec 17 | 0 | -4 | 3 | 0 |
30 Sep 17 | 0 | -4 | 3 | 0 |
30 Jun 17 | 0 | -4 | 3 | 0 |
31 Dec 16 | 0 | -4 | 3 | 0 |
30 Sep 16 | 0 | -4 | 3 | 0 |
30 Jun 16 | 0 | -3 | 2 | 0 |
31 Dec 15 | 0 | -1 | 1 | 0 |
Des revenus de qualité: NTI is currently unprofitable.
Augmentation de la marge bénéficiaire: NTI is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: NTI is unprofitable, and losses have increased over the past 5 years at a rate of 10.5% per year.
Accélération de la croissance: Unable to compare NTI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: NTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Rendement des fonds propres
ROE élevé: NTI has a negative Return on Equity (-103.92%), as it is currently unprofitable.